Fischer, S. and Zechmeister-Koss, I. (2012): Radiofrequency Ablation for the Treatment of Head and Neck Cancer. Decision Support Document 55.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
This systematic review evaluated radiofrequency ablation (RFA) for the treatment of head and neck cancer. A systematic literature search in various databases was supplemented by a handsearch.
Overall, we identified one case series of 21 patients aged around 63 years with various recurrent or unresectable/inoperable head and neck cancer. Follow-up was about 44 days and the drop-out rate was 38%. Besides a marginal improvement in quality of life, the median survival was four months. There was a high rate (45%) of serious complications. Moreover, the procedure-related mortality was 5%.
Due to the uncontrolled study design of the included case series, the available evidence is insufficient for assessing the efficacy and safety of RFA compared to the respective standard therapy for the treatment of head and neck cancer.
|Item Type:||Decision Support Document|
|Keywords:||radiofrequency ablation, RFA, tumor ablation, tumour ablation, thyroid cancer, head cancer, neck cancer|
|Subjects:||WV Otolaryngology > WV 300-358 Nose and paranasal sinuses|
WV Otolaryngology > WV 500-540 Larynx
WO Surgery > WO 500-517 Operative surgical procedures. Techniques
WV Otolaryngology > WV 400-440 Pharyngeal region
WO Surgery > WO 505 Minimally invasive surgical procedures
WV Otolaryngology > WV 200-290 Ear
|Series Name:||Decision Support Document 55|
|Deposited on:||23 Jul 2012 19:47|
|Last Modified:||23 Jul 2012 19:47|
Repository Staff Only: item control page